Related Experiment Video
Updated: Jun 21, 2026

Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry
Published on: May 24, 2024
Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy
M Falcone1, M Perilli, M L Mezzatesta
1Dipartimento di Medicina Clinica, Policlinico Umberto I, University of Rome La Sapienza, Rome, Italy.
Abstract:
Persistent bacteraemia arising from a case of post-operative mediastinitis as a result of a Proteus mirabilis isolate, possessing two class 1 integrons carrying bla(VIM-1) and aadA2 gene cassettes located on chromosomal and plasmidic DNA, respectively, is reported. Despite the in vitro susceptibility to carbapenems, meropenem therapy failed, whereas the patient responded to treatment with cefepime plus amikacin. To our knowledge, this is the first report of metallo-beta-lactamase production in a clinical isolate of P. mirabilis in Italy.
Insights
A Proteus mirabilis infection resistant to meropenem, despite in vitro susceptibility, highlights the emergence of metallo-beta-lactamase in Italy. The patient recovered with cefepime and amikacin treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Post-operative mediastinitis can lead to persistent bloodstream infections.
- Proteus mirabilis is an opportunistic pathogen.
- Integrons are genetic elements that confer antibiotic resistance.
Observation:
- A clinical isolate of Proteus mirabilis exhibited persistent bacteremia.
- The isolate possessed two class 1 integrons with bla(VIM-1) and aadA2 gene cassettes.
- These resistance genes were located on both chromosomal and plasmid DNA.
Findings:
- The Proteus mirabilis isolate showed in vitro susceptibility to carbapenems.
- Meropenem therapy was ineffective in treating the patient's persistent bacteremia.
- The patient responded successfully to cefepime plus amikacin.
Implications:
- This is the first report of metallo-beta-lactamase (VIM-1) production in a clinical Proteus mirabilis isolate in Italy.
- The findings underscore the importance of monitoring emerging antibiotic resistance mechanisms.
- Treatment strategies may need to be adjusted for infections caused by metallo-beta-lactamase-producing Enterobacterales.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Automated Microbial Diagnostics
Bacterial Meningitis
Bacterial Gastroenteritis
Bacterial Meningitis I: Introduction
